# Heqet Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/heqet-therapeutics

- Industry: Biotechnology
- Headquarters: Turin, Italy
- Website: www.heqettherapeutics.com
- Total disclosed funding: $8.7M
- Latest round: Series A (Mar 23, 2022)
- Investors on record: 2

## About

Based in Turin, Italy, Heqet Therapeutics operates as a provider of healthcare platform that targets the treatment of cardiovascular diseases. In March 2022, Heqet Therapeutics, led by its CEO Marta Antonucci, raised GBP 6.6 million in series A funding co-led by new investors 2Invest and Claris Ventures.

The company creates cutting-edge genetic therapeutics to combat the effects of ischemic heart disease.

The company intends to use the funds raised in March 2022 for the development of its current projects.

## Funding rounds

- Series A, Mar 23, 2022, $8.7M — Claris Ventures, 2Invest

## Investors

- Claris Ventures (https://capitalatlas.ai/funds/claris-ventures) — Series A
- 2Invest — Series A